Lazanda Nasal Spray and Mogamulizumab-kpkc Intravenous
Determining the interaction of Lazanda Nasal Spray and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fentanyl
Brand name: Lazanda, Abstral, Fentora, Subsys, Actiq, Duragesic, Ionsys, Onsolis, Sublimaze
Synonyms: n.a.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lazanda Nasal Spray-Molindone
- Lazanda Nasal Spray-Mometasone (Oral Inhalation)
- Lazanda Nasal Spray-Mometasone and Formoterol
- Lazanda Nasal Spray-Mometasone and formoterol Inhalation
- Lazanda Nasal Spray-Mometasone Cream
- Lazanda Nasal Spray-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Leader Acid Control
- Mogamulizumab-kpkc Intravenous-Leader Acid Reducer Maximum Strength
- Mogamulizumab-kpkc Intravenous-Leader All Day Allergy
- Mogamulizumab-kpkc Intravenous-Leader Allergy D 12
- Mogamulizumab-kpkc Intravenous-Leader Allergy Relief
- Mogamulizumab-kpkc Intravenous-Leader Allergy Relief D-24